Sam S. Chang MD, MBA
Professor, Department of Urology; Patricia and Rodes Hart Professor of Urologic Surgery; Chief Surgical Officer, Vanderbilt Ingram Cancer Center; Chief, Division of Urologic Oncology, Vanderbilt University, Nashville, TennesseeAfter completing his education and training at Princeton University, Vanderbilt University, and Memorial Sloan-Kettering, Dr. Chang returned to Nashville and is currently Professor of Urologic Surgery. Focusing on urologic oncology and education, he has led efforts in integration of evidence-based medicine in clinical pathways, enhanced guidelines formulation, and improved cancer staging as chair of the AJCC GU Staging Panel and as a CoC member. He was the vice-chair of the AUA Guidelines on Noninvasive Bladder Cancer and the facilitator for the AUA Renal Cancer Follow-up Guidelines. Dr. Chang has authored more than 200 original publications. For his academic efforts, he received the SUO’s first-ever Distinguished Service Award, the CaPCURE Young Investigator Award, and has been twice named a Journal of Urology’s Best Reviewer. Dr. Chang was recently honored with the American Urological Association Gold Cystoscope Award.
Recent Contributions to PracticeUpdate:
- Changes in Glomerular Filtration Rate After Neoadjuvant Chemotherapy Prior to Nephroureterectomy for UTUC
- Role of Lymphadenectomy During Radical Cystectomy for Non–Muscle Invasive Bladder Cancer
- Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy
- European Association of Urology Guidelines on Muscle-Invasive and Metastatic Bladder Cancer
- Initial Experience With Novel Single-Use Disposable Ureteroscopy
- Site of Metastatic Recurrence Impacts Prognosis in Patients With High-Grade Upper Tract Urothelial Carcinoma
- Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients With Bladder Cancer
- Effects of the Hospital Readmissions Reduction Program on Radical Cystectomy Readmissions
- Non-Urothelial Variant Histology and Oncological Outcomes Following Radical Cystectomy
- Distal Ureter Management During Nephroureterectomy